Cerenome vs Charming Medical
Cerenome and Charming Medical are similar in size: $5.2m and $4.8m of revenue in their latest fiscal years. Cerenome grew faster (-10.5% against -22.7%). Charming Medical kept more of each dollar of sales as profit: a net margin of -0.5% against -429.4%. Charming Medical carries less debt relative to equity (7.2% against 18.8%).
| Latest fiscal year | CerenomeCNSY, 2025 | Charming MedicalMCTA, 2026 |
|---|---|---|
| Revenue | $5.2m | $4.8m |
| Revenue growth | -10.5% | -22.7% |
| Net income | −$22.4m | −$22,648 |
| Operating margin | -293.5% | -0.6% |
| Net margin | -429.4% | -0.5% |
| Return on equity | — | -0.9% |
| Free cash flow | −$20.8m | −$1.6m |
| Cash | $4.3m | $4.7m |
| Total debt | $750,000 | $371,598 |
| Debt to equity | 18.8% | 7.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 28 | — |
| Market value | $9.6m | $474m |
| Price vs our value range | — | — |
| Moat score | 18 (Weak) | — |
| Insider trades, 12 months | 1 buys, 0 sales | 0 buys, 0 sales |